10x Genomics, Inc. Class A Common Stock, also called 10x Genomics, is a life science technology company, which engages in building products to interrogate, understand and master biology. Read More Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA. The listed name for TXG is 10x Genomics, Inc. Class A Common Stock.